ReviewFrontiers in oncology2022

Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials.

Yan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.